NCT05576493 is a NA clinical trial of phaco+MP-TSCPC in Angle Closure Glaucoma, sponsored by Cairo University.

Who is sponsoring NCT05576493?

NCT05576493 is sponsored by Cairo University.

What drugs are being tested in NCT05576493?

Interventions in NCT05576493: phaco+MP-TSCPC, phaco+TSCPC, phaco+endocyclophotocoagulation, phaco GSL.

What condition does NCT05576493 study?

NCT05576493 studies Angle Closure Glaucoma.

Is NCT05576493 still recruiting?

NCT05576493 is currently status unknown. Last updated 30 August 2023.

Last reviewed 2023-08-30 · How we verify

NCT05576493

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma

Status unknown NA Last updated 30 August 2023

What this trial tests

NA trial testing phaco+MP-TSCPC in Angle Closure Glaucoma in 88 participants. Status unknown.

Timeline

11 August 2022

Primary endpoint
1 October 2023

1 December 2023

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	88
Start date	11 August 2022
Primary completion	1 October 2023
Estimated completion	1 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

phaco+MP-TSCPC
phaco+TSCPC
phaco+endocyclophotocoagulation
phaco GSL

Conditions studied

Angle Closure Glaucoma — all drugs for Angle Closure Glaucoma →

Sponsor

Cairo University

Who can join

Adults 20 to 70, any sex, with Angle Closure Glaucoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

comparing different types of cuclophotocoagulation with cataract extraction to cataract extraction and goniocynechiolysis in cases of chronic angle closure glaucoma

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Angle Closure Glaucoma

Currently open trials in the same condition.

NCT07195370 — Testing YAG Laser Iridotomy for Primary Angle-Closure Glaucoma · NA · active not recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05576493 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 30 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05576493.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing